ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jul 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
September 2026
Nuclear Technology
August 2026
Fusion Science and Technology
Latest News
In transition: Commercializing fusion power
Commercial fusion power is closer than ever. There are now around 30 U.S. fusion companies, several of which claim to be on track to connect to the grid as early as the 2030s.
Tokamak and laser inertial confinement approaches benefit from decades of research at facilities such as the National Ignition Facility (NIF) at Lawrence Livermore National Laboratory and ITER, with alternative concepts including stellarator, magnetic mirror, and Z-pinch confinement also making notable progress as private and government funding for fusion increases.
J. Coulot, F. Lavielle, A. Faggiano, N. Bellon, B. Aubert, M. Schlumberger, M. Ricard
Nuclear Science and Engineering | Volume 149 | Number 2 | February 2005 | Pages 124-130
Technical Paper | doi.org/10.13182/NSE05-A2483
Articles are hosted by Taylor and Francis Online.
Standard macroscopic methods used to assess the dose in nuclear medicine are limited to cases of homogeneous radionuclide distributions and provide dose estimations at the organ level. In a few applications, like radioimmunotherapy, the mean dose to an organ is not suitable to explain clinical observations, and knowledge of the dose at the tissular level is mandatory. Therefore, one must determine how particles lose their energy and what is the best way to represent tissues. The Monte Carlo method is appropriate to solve the problem of particle transport, but the question of the geometric representation of biology remains. In this paper, we describe a software (CLUSTER3D) that is able to build randomly biologically representative sphere cluster geometries using a statistical description of tissues. These geometries are then used by our Monte Carlo code called DOSE3D to perform particle transport. First results obtained on thyroid models highlight the need of cellular and tissular data to take into account actual radionuclide distributions in tissues. The flexibility and reliability of the method makes it a useful tool to study the energy deposition at various cellular and tissular levels in any configuration.